• Baris Ciplak, Eyup Gokhan Turmus, Ozlem Kara, Gulcin Daglioglu, Mehmet Murat Altindag, Yavuz Simsek, Yusuf Kenan Daglioglu, and Mustafa Kara.
• Malatya Training and Research Hospital, Clinic of Obstetrics and Gynecology - Malatya, Turkey.
• Rev Assoc Med Bras (1992). 2023 Jan 1; 69 (8): e20230314e20230314.

ObjectiveThe objective of this study was to investigate the protectiveness of resveratrol on cisplatin-induced damage to the ovary using experimental models.MethodsA total of 30 female Wistar-Albino rats constituted the research material. The rats were categorized into three groups: Group 1 was administered one milliliter of 0.9% NaCl solution, Group 2 was administered 7.5 mg/kg cisplatin, and Group 3 was administered 7.5 mg/kg cisplatin and 10 mg/kg resveratrol. Ovaries were extirpated in all groups and subjected to biochemical and histopathological tests. Cisplatin-induced damage to ovarian tissue was graded and scored as the total histopathological findings score. The ovarian function was assessed using immunohistochemical staining for c-kit expression. Rats' malondialdehyde, catalase, and superoxide dismutase levels were determined.ResultsThe histopathological finding score was significantly higher in Group 2 than in other groups (p<0.05). The superoxide dismutase and catalase levels were significantly higher in Group 3 than in Group 2 (p<0.001 for both cases). The malondialdehyde level was significantly higher in Group 2 than in Group 3 (p<0.001).ConclusionThe study findings demonstrated that resveratrol reduced ovarian injury and enhanced biochemical parameters following cisplatin-induced ovary damage in experimental models.

19 keywords...

hide…